{
    "title": "FDA staff finds no new safety problems with Glaxo's asthma drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2999310/FDA-staff-finds-no-new-safety-problems-Glaxos-asthma-drug.html",
    "date": "2015-03-17",
    "keywords": [
        "staff",
        "drug",
        "breo",
        "safety",
        "march",
        "combination",
        "ellipta",
        "laba",
        "gmt",
        "respiratory",
        "treatment",
        "breathing",
        "review",
        "vilanterol",
        "asthma",
        "compound",
        "steroid",
        "market",
        "email",
        "food",
        "administration",
        "meeting",
        "fda",
        "corticosteroid",
        "disease",
        "disability",
        "time",
        "surface",
        "pathwaysvilanterol",
        "class",
        "betaadrenoceptor",
        "theravance",
        "inc",
        "worsening",
        "panel",
        "favor",
        "baird",
        "co",
        "tuesday",
        "http1usagov1fvj3r9the",
        "glaxo",
        "profile",
        "saidthey",
        "fact",
        "benefit",
        "trialsglaxo",
        "warning",
        "risk",
        "deathsthis",
        "sideeffect",
        "study",
        "glaxos",
        "salmeterol",
        "placebosalmeterol",
        "brand",
        "name",
        "diskus",
        "reporting",
        "vidya",
        "l",
        "nathan",
        "amrutha",
        "penumudi",
        "bengaluru",
        "editing",
        "savio",
        "dsouza"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}